These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

250 related items for PubMed ID: 8983283

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Monotherapy with piperacillin/tazobactam versus combination therapy with ceftazidime plus amikacin as an empiric therapy for fever in neutropenic cancer patients.
    Hess U, Böhme C, Rey K, Senn HJ.
    Support Care Cancer; 1998 Jul; 6(4):402-9. PubMed ID: 9695210
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. A comparative study of cefepime versus ceftazidime as empiric therapy of febrile episodes in neutropenic patients.
    Wang FD, Liu CY, Hsu HC, Gau JP, Chau WK, Haung ML, Ho CH.
    Chemotherapy; 1999 Jul; 45(5):370-9. PubMed ID: 10473925
    [Abstract] [Full Text] [Related]

  • 25. Comparison of meropenem with amikacin plus ceftazidime in the empirical treatment of febrile neutropenia: a prospective randomised multicentre trial in patients without previous prophylactic antibiotics. Meropenem Study Group of Turkey.
    Akova M, Akan H, Korten V, Biberoğlu K, Hayran M, Unal S, Kars A, Kansu E.
    Int J Antimicrob Agents; 1999 Sep; 13(1):15-9. PubMed ID: 10563400
    [Abstract] [Full Text] [Related]

  • 26. [Evaluation of three types of empirical antibiotherapy in patients with febrile neutropenia: imipenem-cilastatin versus ceftazidime-vancomycin versus ticarcillin-amikacin-vancomycin].
    Bosseray A, Nicolini F, Brion JP, Michallet M, Hollard D, Stahl JP, Micoud M.
    Pathol Biol (Paris); 1992 Oct; 40(8):797-804. PubMed ID: 1484739
    [Abstract] [Full Text] [Related]

  • 27. Cefepime/amikacin versus ceftazidime/amikacin as empirical therapy for febrile episodes in neutropenic patients: a comparative study. The French Cefepime Study Group.
    Cordonnier C, Herbrecht R, Pico JL, Gardembas M, Delmer A, Delain M, Moreau P, Ladeb S, Nalet V, Rollin C, Gres JJ.
    Clin Infect Dis; 1997 Jan; 24(1):41-51. PubMed ID: 8994754
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. A comparison of aztreonam plus vancomycin and imipenem plus vancomycin as initial therapy for febrile neutropenic cancer patients.
    Raad II, Whimbey EE, Rolston KV, Abi-Said D, Hachem RY, Pandya RG, Ghaddar HM, Karl CL, Bodey GP.
    Cancer; 1996 Apr 01; 77(7):1386-94. PubMed ID: 8608520
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Treatment of febrile episodes in neutropenic leukemic patients with the antibiotic combinations piperacillin or ceftazidime plus amikacin: results of a randomized study.
    Fenu S, Raccah R, Santilli S, Micozzi A, Girmena C, Martino P, Avvisati G.
    Chemioterapia; 1988 Oct 01; 7(5):323-6. PubMed ID: 3066517
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Comparison of meropenem with ceftazidime as monotherapy of cancer patients with chemotherapy induced febrile neutropenia.
    Malik I, Shaharyar.
    J Pak Med Assoc; 2002 Jan 01; 52(1):15-8. PubMed ID: 11963577
    [Abstract] [Full Text] [Related]

  • 35. Experience with cefepime versus meropenem as empiric monotherapy for neutropenia and fever in pediatric patients with solid tumors.
    Oguz A, Karadeniz C, Citak EC, Cil V, Eldes N.
    Pediatr Hematol Oncol; 2006 Jan 01; 23(3):245-53. PubMed ID: 16517540
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Trimethoprim-sulfamethoxazole plus amikacin versus ceftazidime monotherapy as empirical treatment in patients with neutropenia and fever.
    Engervall P, Günther G, Ljungman P, Lönnqvist B, Hast R, Stiernstedt G, Kalin M, Ringertz S, Bjökholm M.
    Scand J Infect Dis; 1996 Jan 01; 28(3):297-303. PubMed ID: 8863366
    [Abstract] [Full Text] [Related]

  • 38. Management of fever in neutropenic patients with acute leukemia: current role of ceftazidime plus amikacin as empiric therapy.
    Fanci R, Paci C, Martinez RL, Fabbri A, Pecile P, Leoni F, Longo G.
    J Chemother; 2000 Jun 01; 12(3):232-9. PubMed ID: 10877519
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. [Febrile neutropenia: empiric antibiotic therapy from 1975 to 1997].
    Klastersky J.
    Rev Med Brux; 1997 Oct 01; 18(5):323-7. PubMed ID: 9441328
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 13.